<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><title>News on Crestor</title><link href="http://www.aboutprescriptiondrugs.com/topic/Crestor" rel="alternate"></link><id>http://www.aboutprescriptiondrugs.com/topic/Crestor</id><updated>2010-03-05T09:24:22Z</updated><entry><title>FDA Approves New Use for Crestor</title><link href="http://www.aboutprescriptiondrugs.com/article/FDA%20Approves%20New%20Use%20for%20Crestor" rel="alternate"></link><updated>2010-02-22T10:25:10Z</updated><author><name>consumeraffairs.com</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-22:/article/FDA%20Approves%20New%20Use%20for%20Crestor</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;New indication for people 50 and older&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; (FDA) has approved the cholesterol-lowering medication &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; (rosuvastatin) for some patients who are at increased risk of heart disease even though they have not been diagnosed with it.&amp;amp;lt;/p&amp;amp;gt;...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="St. Petersburg"></category><category term="ConsumerAffairs.com"></category><category term="Cardiovascular Medicine"></category><category term="Eric Colman"></category></entry><entry><title>AstraZeneca gets OK for expanded Crestor use</title><link href="http://www.aboutprescriptiondrugs.com/article/AstraZeneca%20gets%20OK%20for%20expanded%20Crestor%20use" rel="alternate"></link><updated>2010-02-22T10:42:47Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-22:/article/AstraZeneca%20gets%20OK%20for%20expanded%20Crestor%20use</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Federal regulators have granted &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; approval to market its cholesterol pill &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; deci...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Proper drug-taking would greatly cut heart risks</title><link href="http://www.aboutprescriptiondrugs.com/article/Proper%20drug-taking%20would%20greatly%20cut%20heart%20risks" rel="alternate"></link><updated>2010-02-22T21:57:55Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-22:/article/Proper%20drug-taking%20would%20greatly%20cut%20heart%20risks</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;LONDON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Encouraging more patients to continue taking their prescribed cholesterol drugs would stave off twice as many stroke and heart attack deaths as giving the drugs to a wider range of people, scientists said on Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A study by British researchers suggested that rather than widening the pool of patients, as recommended by U.S. government healt...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Western Europe"></category><category term="Reuters Group plc"></category><category term="Oceania"></category><category term="Cardiovascular Medicine"></category><category term="Amir Shroufi"></category></entry><entry><title>Business Highlights</title><link href="http://www.aboutprescriptiondrugs.com/article/Business%20Highlights" rel="alternate"></link><updated>2010-02-23T15:35:40Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-23:/article/Business%20Highlights</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Hints of inflation, but experts aren't worried&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (AP) — The economy flashed a warning sign of inflation Tuesday, but the recovery is so fragile that experts say a doomsday scenario of runaway prices and higher interest rates is a long way off, if it happens at all.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;While the &lt;a title="U.S. Federal Reserve" href="/topic/U.S.+Federal+Reserve" &gt;Federal Reserve&lt;/a&gt; is all but certain to t...</summary><category term="Company Activities and Information"></category><category term="Corporate Reporting"></category><category term="Earnings and Losses"></category><category term="Financial Markets"></category><category term="Stock Performance"></category><category term="Dow Jones Industrial Average"></category><category term="National Economy"></category><category term="U.S. National Economy"></category><category term="Public Finance"></category><category term="Cholesterol"></category><category term="Central Banking"></category><category term="Medicare"></category><category term="Wall Street"></category><category term="Western Europe"></category><category term="Adobe Systems Inc."></category><category term="Best Buy Co. Inc."></category><category term="The Associated Press"></category><category term="General Electric Company"></category><category term="Boeing Company"></category><category term="Federal Aviation Administration"></category><category term="General Electric Capital Corporation"></category><category term="Jeffrey Immelt"></category><category term="Boeing 787"></category><category term="Cormac Carney"></category><category term="Everett (Washington)"></category><category term="Boeing Field"></category><category term="Cardiovascular Medicine"></category><category term="London (England)"></category><category term="Lori Gunter"></category><category term="Raj Rajaratnam"></category><category term="NASDAQ Composite Index"></category><category term="New York Mercantile Exchange"></category><category term="Brooklyn (New York City)"></category><category term="Financial Market Indices"></category></entry><entry><title>FDA panel backs new use for AstraZeneca's Crestor</title><link href="http://www.aboutprescriptiondrugs.com/article/FDA%20panel%20backs%20new%20use%20for%20AstraZeneca%27s%20Crestor" rel="alternate"></link><updated>2010-02-23T15:38:36Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-23:/article/FDA%20panel%20backs%20new%20use%20for%20AstraZeneca%27s%20Crestor</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Federal health advisers said Tuesday that expanded use of &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt;'s cholesterol pill &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; can benefit patients with healthy cholesterol levels by preventing heart attack, stroke and death.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A &lt;a title="Food and Drug Administration" href="/topic/Food+and+Drug+Administration" &gt;Food and Drug Administration&lt;/a&gt; pan...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Apotex Inc."></category><category term="Howard Hutchinson"></category><category term="Cardiovascular Medicine"></category><category term="Mylan Inc."></category><category term="Michael Proschan"></category></entry><entry><title>U.S. panel backs wider use of AstraZeneca's Crestor</title><link href="http://www.aboutprescriptiondrugs.com/article/U.S.%20panel%20backs%20wider%20use%20of%20AstraZeneca%27s%20Crestor" rel="alternate"></link><updated>2010-02-23T15:36:51Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-23:/article/U.S.%20panel%20backs%20wider%20use%20of%20AstraZeneca%27s%20Crestor</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&lt;a title="Gaithersburg" href="/topic/Gaithersburg" &gt;GAITHERSBURG&lt;/a&gt;, &lt;a title="Maryland" href="/topic/Maryland" &gt;Maryland&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; won a &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; panel's support on Tuesday for its bid to promote the cholesterol-lowering pill &lt;a title="Crestor" href="/topic/...</summary><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Richard Chang"></category><category term="Cardiovascular Medicine"></category><category term="Lisa Richwine"></category><category term="New York Stock Exchange"></category></entry><entry><title>U.S. panel to weigh safety of AstraZeneca's Crestor</title><link href="http://www.aboutprescriptiondrugs.com/article/U.S.%20panel%20to%20weigh%20safety%20of%20AstraZeneca%27s%20Crestor" rel="alternate"></link><updated>2010-02-23T17:33:41Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-23:/article/U.S.%20panel%20to%20weigh%20safety%20of%20AstraZeneca%27s%20Crestor</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - U.S. regulators see benefits to using an &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca Plc&lt;/a&gt; cholesterol drug in a vast new group of patients but will ask outside advisers to probe various safety issues, documents released on Friday said.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;AstraZeneca wants permission to promote the drug, &lt;a title="Crestor" hre...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="East Asia"></category><category term="Ben Hirschler"></category><category term="Cardiovascular Medicine"></category><category term="Lisa Richwine"></category><category term="Gerald E. McCormick"></category><category term="New York Stock Exchange"></category><category term="Brian Bourdot"></category></entry><entry><title>FDA confirms benefits of Crestor in more patients</title><link href="http://www.aboutprescriptiondrugs.com/article/FDA%20confirms%20benefits%20of%20Crestor%20in%20more%20patients" rel="alternate"></link><updated>2010-02-23T17:37:58Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-23:/article/FDA%20confirms%20benefits%20of%20Crestor%20in%20more%20patients</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;FDA says cholesterol pill &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; curbs heart problems in patients, but notes diabetes risk&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Federal scientists say &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt;'s cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain.&amp;amp;lt;/p&amp;am...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Internal Medicine"></category><category term="Gastrointestinal Disorders"></category><category term="Metabolic Disorders"></category><category term="Diabetes"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Crestor shows equal or better benefit to women</title><link href="http://www.aboutprescriptiondrugs.com/article/Crestor%20shows%20equal%20or%20better%20benefit%20to%20women" rel="alternate"></link><updated>2010-02-24T04:10:13Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-24:/article/Crestor%20shows%20equal%20or%20better%20benefit%20to%20women</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;ORLANDO, &lt;a title="Florida" href="/topic/Florida" &gt;Florida&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A fresh look at data from a landmark study showed that &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt;'s powerful cholesterol fighter &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; dramatically cut deaths, heart attacks and strokes in women at least as much as in men, providing new evi...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Richard Chang"></category><category term="Paul Ridker"></category><category term="Cardiovascular Medicine"></category><category term="Ransdell Pierson"></category><category term="Alex Gold"></category><category term="Center for Cardiovascular Disease Prevention"></category></entry><entry><title>Low cholesterol may prevent some prostate cancers</title><link href="http://www.aboutprescriptiondrugs.com/article/Low%20cholesterol%20may%20prevent%20some%20prostate%20cancers" rel="alternate"></link><updated>2010-02-24T10:29:56Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-24:/article/Low%20cholesterol%20may%20prevent%20some%20prostate%20cancers</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;Keeping cholesterol low may help men avoid aggressive prostate cancers, study suggests&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Men may protect more than their hearts if they keep cholesterol in line: Their chances of getting aggressive prostate cancer may be lower, new research suggests.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;One study found that men whose cholesterol was in a healthy range — below 200 — had less than half the risk of developing high-gr...</summary><category term="Cancer"></category><category term="Prostate Cancer"></category><category term="Cholesterol"></category><category term="Sexual and Reproductive Health"></category><category term="Men's Health"></category><category term="American Association for Cancer Research"></category><category term="Cardiovascular Medicine"></category><category term="Elizabeth Platz"></category><category term="Demetrius Albanes"></category><category term="Eric Jacobs"></category><category term="Susan Gapstur"></category></entry><entry><title>Study finds even more may benefit from statin use</title><link href="http://www.aboutprescriptiondrugs.com/article/Study%20finds%20even%20more%20may%20benefit%20from%20statin%20use" rel="alternate"></link><updated>2010-02-25T04:03:42Z</updated><author><name>Reuters US Online Report Health News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-25:/article/Study%20finds%20even%20more%20may%20benefit%20from%20statin%20use</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&lt;a title="Chicago" href="/topic/Chicago" &gt;CHICAGO&lt;/a&gt; (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - Apparently healthy people with normal or even low cholesterol levels might benefit as much from taking statin drugs as people with high cholesterol, &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; researchers said on Tuesday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;They studied people with normal cholesterol readings but ...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Maggie Fox"></category><category term="Paul Ridker"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>U.S. group questions AstraZeneca's Crestor patent</title><link href="http://www.aboutprescriptiondrugs.com/article/U.S.%20group%20questions%20AstraZeneca%27s%20Crestor%20patent" rel="alternate"></link><updated>2010-02-26T14:50:32Z</updated><author><name>Reuters US Online Report Business News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-26:/article/U.S.%20group%20questions%20AstraZeneca%27s%20Crestor%20patent</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;WASHINGTON (&lt;a title="Reuters Group plc" href="/topic/Reuters+Group+plc" &gt;Reuters&lt;/a&gt;) - A &lt;a title="United States" href="/topic/United+States" &gt;U.S.&lt;/a&gt; patent research group says it has uncovered evidence that could be used to declare &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca Plc&lt;/a&gt;'s &amp;amp;amp;lt;AZN.L&amp;amp;amp;gt;&amp;amp;amp;lt;AZN.N&amp;amp;amp;gt; patent for its cholesterol fighter &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor...</summary><category term="Law"></category><category term="Intellectual Property"></category><category term="Patents"></category><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Reuters Group plc"></category><category term="Cheryl Milone"></category><category term="Cardiovascular Medicine"></category><category term="Diane Bartz"></category><category term="Article One Partners LLC"></category></entry><entry><title>Abbott, AstraZeneca seek cholesterol pill approval</title><link href="http://www.aboutprescriptiondrugs.com/article/Abbott%2C%20AstraZeneca%20seek%20cholesterol%20pill%20approval" rel="alternate"></link><updated>2010-02-27T01:48:53Z</updated><author><name>AP News</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-02-27:/article/Abbott%2C%20AstraZeneca%20seek%20cholesterol%20pill%20approval</id><summary type="html">&amp;amp;lt;div id="subtitle"&amp;amp;gt;Abbott and &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; seek &lt;a title="United States" href="/topic/United+States" &gt;US&lt;/a&gt; approval for cholesterol drug combining &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; and &lt;a title="Trilipix" href="/topic/Trilipix" &gt;Trilipix&lt;/a&gt;&amp;amp;lt;/div&amp;amp;gt;&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&lt;a title="Abbott Laboratories Inc." href="/topic/Abbott+Laboratories+Inc." &gt;Abbott Laboratories&lt;/a&gt; an...</summary><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="Western Europe"></category><category term="Abbott Laboratories Inc."></category><category term="Cardiovascular Medicine"></category><category term="Trilipix"></category><category term="London (England)"></category></entry><entry><title>Cholesterol drug cuts vein clot risk by 40 percent</title><link href="http://www.aboutprescriptiondrugs.com/article/Cholesterol%20drug%20cuts%20vein%20clot%20risk%20by%2040%20percent" rel="alternate"></link><updated>2010-03-03T13:05:29Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-03:/article/Cholesterol%20drug%20cuts%20vein%20clot%20risk%20by%2040%20percent</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The cholesterol-fighting drug rosuvastatin, marketed as &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; to help fight high cholesterol, can help cut the risk of blood clots dramatically, according to research released Sunday.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The study dubbed Jupiter -- Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin -- found that taking the British lab &lt;a title="AstraZeneca Group" href="...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Vascular Disorders"></category><category term="Venous Disorders"></category><category term="Stroke"></category><category term="Public Citizen Foundation"></category><category term="Paul Ridker"></category><category term="Robert D. Glynn"></category><category term="Blood Disorders"></category><category term="Cardiovascular Medicine"></category><category term="Brain and Nerve Health"></category></entry><entry><title>Study: Cholesterol drug lowers blood clot risk</title><link href="http://www.aboutprescriptiondrugs.com/article/Study%3A%20Cholesterol%20drug%20lowers%20blood%20clot%20risk" rel="alternate"></link><updated>2010-03-03T13:10:31Z</updated><author><name>AP Features</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-03:/article/Study%3A%20Cholesterol%20drug%20lowers%20blood%20clot%20risk</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Statin drugs, taken by millions of Americans to lower cholesterol and prevent heart disease, also can cut the risk of developing dangerous blood clots that can lodge in the legs or lungs, a major study suggests.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The results provide a new reason for many people with normal cholesterol to consider taking these medicines, sold as &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt;, &lt;a title="Lipitor" href="/topic/Lipitor" &gt;Lipi...</summary><category term="Cholesterol"></category><category term="Vascular Disorders"></category><category term="Venous Disorders"></category><category term="New England States"></category><category term="Mark Hlatky"></category><category term="Public Citizen Foundation"></category><category term="Paul Ridker"></category><category term="Robert D. Glynn"></category><category term="James Stein"></category><category term="Thomas Pearson"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Specialists to review global fight on heart disease</title><link href="http://www.aboutprescriptiondrugs.com/article/Specialists%20to%20review%20global%20fight%20on%20heart%20disease" rel="alternate"></link><updated>2010-03-03T17:07:13Z</updated><author><name>AFP Global Edition</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-03:/article/Specialists%20to%20review%20global%20fight%20on%20heart%20disease</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Heart specialists from around the world meet this weekend in &lt;a title="Orlando (Florida)" href="/topic/Orlando+(Florida)" &gt;Orlando, Florida&lt;/a&gt; to discuss landmarks developments in battling cardio disease.&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;The 58th annual convention of the &lt;a title="American College of Cardiology" href="/topic/American+College+of+Cardiology" &gt;American College of Cardiology&lt;/a&gt; is set to learn the results of some 30 clinical trials and join for...</summary><category term="Cholesterol"></category><category term="Technology"></category><category term="Medical Technology"></category><category term="Aaron Kugelmass"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>Statins (Rosuvastatin) And Their Use Among People With Normal "Bad" Cholesterol (LDL) Levels</title><link href="http://www.aboutprescriptiondrugs.com/article/Statins%20%28Rosuvastatin%29%20And%20Their%20Use%20Among%20People%20With%20Normal%20%22Bad%22%20Cholesterol%20%28LDL%29%20Levels" rel="alternate"></link><updated>2009-03-13T14:55:57Z</updated><author><name>ezinearticles.com</name></author><id>tag:www.aboutprescriptiondrugs.com,2009-03-13:/article/Statins%20%28Rosuvastatin%29%20And%20Their%20Use%20Among%20People%20With%20Normal%20%22Bad%22%20Cholesterol%20%28LDL%29%20Levels</id><summary type="html">&lt;p&gt;&amp;lt;p&amp;gt;Statins (Rosuvastatin) And Their Use Among People With Normal "Bad" Cholesterol (LDL) Levels&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;By Salvatore Docimo&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;&amp;lt;/p&amp;gt;&amp;lt;p&amp;gt;Statins, also known as HMG-CoA reductase inhibitors, are a class of drugs that reduce the level of "bad" cholesterol in your blood known as low-density lipoprotein cholesterol (LDL-c). Statin therapy has been approved for patients who have been diagnosed with vascular disease, diabetes, or who have an increased level o...</summary><category term="Medicine"></category><category term="Medical Specializations"></category><category term="Cardiology"></category><category term="Cholesterol"></category><category term="Heart Attacks"></category></entry><entry><title>Crestor Reduces the Risk of Cardiovascular Events For Much Fewer Than One Hundred Twenty of Us</title><link href="http://www.aboutprescriptiondrugs.com/article/Crestor%20Reduces%20the%20Risk%20of%20Cardiovascular%20Events%20For%20Much%20Fewer%20Than%20One%20Hundred%20Twenty%20of%20Us" rel="alternate"></link><updated>2010-03-05T09:24:22Z</updated><author><name>ezinearticles.com</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-05:/article/Crestor%20Reduces%20the%20Risk%20of%20Cardiovascular%20Events%20For%20Much%20Fewer%20Than%20One%20Hundred%20Twenty%20of%20Us</id><summary type="html">&lt;p&gt;&amp;amp;lt;p&amp;amp;gt;&lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt; Reduces The Risk Of Cardiovascular Events For Much Fewer Than One Hundred Twenty Of Us&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;By [Http://Ezinearticles.Com/?Expert=Bentley_Thompson]Bentley Thompson&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;&amp;amp;lt;/p&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Those Cholesterol Numbers Can Be Tricky, And So Are The Reports And Advertisements You Hear. The Makers Of Statin Medications Want All Of Us To Take Statins, Whether...</summary><category term="Cholesterol"></category><category term="Heart Attacks"></category><category term="Stroke"></category><category term="Cardiovascular Medicine"></category><category term="Brain and Nerve Health"></category></entry><entry><title>THE CRESTOR CONUNDRUM</title><link href="http://www.aboutprescriptiondrugs.com/article/THE%20CRESTOR%20CONUNDRUM" rel="alternate"></link><updated>2010-03-01T15:53:08Z</updated><author><name>BusinessWeek</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-01:/article/THE%20CRESTOR%20CONUNDRUM</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;h1&amp;amp;gt; THE CRESTOR CONUNDRUM
			&amp;amp;lt;/h1&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;A groundbreaking 18,000-patient study called Jupiter dominated the AHA meeting. It found that &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt;'s &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt;, a cholesterol-lowering statin, reduced the number of heart attacks, strokes, and other events by 44%--results that will likely increase demand for statins. But some scienti...</summary><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="BusinessWeek Magazine"></category><category term="Sharonne Hayes"></category><category term="Cardiovascular Medicine"></category></entry><entry><title>STATINS GET A LIFT</title><link href="http://www.aboutprescriptiondrugs.com/article/STATINS%20GET%20A%20LIFT" rel="alternate"></link><updated>2010-03-01T15:56:15Z</updated><author><name>BusinessWeek</name></author><id>tag:www.aboutprescriptiondrugs.com,2010-03-01:/article/STATINS%20GET%20A%20LIFT</id><summary type="html">&amp;amp;lt;div&amp;amp;gt;&amp;amp;lt;h1&amp;amp;gt; STATINS GET A LIFT
			&amp;amp;lt;/h1&amp;amp;gt;&amp;amp;lt;p&amp;amp;gt;Pharma's big studies cost megabucks, but sometimes they really, really pay off. On Nov. 9, &lt;a title="AstraZeneca Group" href="/topic/AstraZeneca+Group" &gt;AstraZeneca&lt;/a&gt; revealed the results of a huge study of &lt;a title="Crestor" href="/topic/Crestor" &gt;Crestor&lt;/a&gt;, its cholesterol-busting statin. The 18,000-patient Jupiter study found that Crestor can cut heart attacks and strokes by 45% in people with ...</summary><category term="Cholesterol"></category><category term="Biotechnology Sector"></category><category term="Pharmaceuticals Sector"></category><category term="BusinessWeek Magazine"></category><category term="Cardiovascular Medicine"></category></entry></feed>